People suffering from migraine know that to prevent attacks is almost impossible. However, scientists managed to create a drug that can solve this problem. The medicine passed a three-month trial on people suffering from migraine.

The principle of action is comparable with the work of antibodies that attack certain compounds in the chains of chemical reactions underlying the attacks. More recently, it was believed that the cause of migraine is a sharp widening and narrowing of the vessels of the head. Today, for certain it is known: these are consequences. The disease can occur with different symptoms, nakatyvayuschie headaches can be accompanied by nausea, loss of strength, flashes of light.

Migraine occurs in the brain and is accompanied by an increase in the concentration of peptide. The new agent blocks it, not allowing to join the receptors. Scientists have created two forms of the drug, and studies have shown that both are quite effective. The first one was examined for 160 subjects suffering from migraine for at least 14 days per month. Four months after the start of the drug, 16% of the pain disappeared completely, 33% became rare. The second form of the drug gave similar results.

nmkd. en.

Keywords:.